Medicine Overview of Dynaglipt-M 500mg/20mg Tablet
Nausea, Altered taste, Diarrhoea, Stomach pain, Loss of appetite, Headache, Hypoglycaemia (low blood sugar level) in combination with insulin or sulphonylurea, Upper respiratory tract infection, Nasopharyngitis.
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Dynaglipt-M 500mg/20mg Tablet is to be taken with food.
Dynaglipt-M 500mg/20mg Tablet may cause stomach upset if taken on empty stomach.
Dynaglipt-M 500mg/20mg Tablet is a combination of two antidiabetic medicines: Metformin and teneligliptin. Metformin is a biguanide which decreases the production and absorption of sugar in your body and allows better use of existing insulin.Teneligliptin is a dipeptidyl peptidase-4 inhibitor which works by increasing the release of insulin from pancreas and decreasing the hormones that raise blood sugar levels. This reduces both fasting and postmeal sugar levels. Together, they provide better control of blood sugar.
In Depth Information on Dynaglipt-M 500mg/20mg Tablet
Dynaglipt-M Tablet related warnings
Taking metformin with alcohol can cause lactic acidosis and
you may experience malaise, respiratory distress, slow or irregular heartbeat, sleepiness, stomach upset, or other unusual symptoms.
Unknown. Human and animal studies are not available. Please consult your doctor.
No information is available on the use of Dynaglipt-M 500mg/
20mg Tablet during lactation. Please consult your doctor.
Your ability to drive may be affected if your blood sugar is
low or high. If this happens, do not drive.
Dynaglipt-M 500mg/20mg Tablet should be used with caution in patients with kidney disease. Dose adjustment of Dynaglipt-M 500mg/20mg Tablet may be needed. Please consult your doctor.
Use of Dynaglipt-M 500mg/20mg Tablet is, however, not recommended in patients with severe kidney disease. Regular monitoring of kidney function test is advisable while you are taking this medicine.
Dynaglipt-M 500mg/20mg Tablet should be used with caution in patients with liver disease. Dose adjustment of Dynaglipt-M 500mg/20mg Tablet may be needed. Please consult your doctor.
Dynaglipt-M 500mg/20mg Tablet is generally started with low dose in patients with mild to moderate liver disease and its use is not recommended in patients with severe liver disease.
No Patient Concerns found for this medicine
User Submitted Feedback For Dynaglipt-M 500mg/20mg Tablet
Patients taking Dynaglipt-M 500mg/20mg Tablet What were the side-effects while using this medicine? How do you take this medicine? How much was the improvement? Please rate this medicine on price? What are you using this medicine for?
Survey Participants: 28
“The following are the results of on-going survey on 1mg.com for Dynaglipt-M 500mg/20mg Tablet. These results only indicate the perceptions of the website users. Please base your medical decisions only on the advice of a doctor or a registered medical professional.”
One of the following vendor pharmacies will deliver Dynaglipt-M 500mg/20mg Tablet: PVP, DGN, DPP, SSA, SWA, VRS, GTC, HBV, PWN, BSN, NSL, RHW, NXG, SDM, SAF, MDO, FGH, UMP, JVN, ANT, LCC, HIP, MAX, SBA, OHM, ATL, THP, ARD, HAT, JMJ, STA, DYG, NWP, AYU, LHA, RSA, MLC, DFP, KHH, RHL, RSS, ZVP, USF, GNC, IPL, EMB, DDR, IAD, HGI, OLT, OIP, OWP, SWP, HMP, DLP, SCH, TRP, NTB, GPP, ZEL, SJP, DHR, PTI, RPP, SAT, PRN, TNH, WSI, SHD, SGC, NDP, RJH, SYN, INC, GTK, ADT, DPL, NVY, HPC, JIV, AMR, ATP, ABP, MAM, SVH, RUS, PLT, BMJ, HEX, RWP, NVL, AAY, WHL, AGT, JVO, BDN, BAL, GPT, BHP, MMS, NNH, SBL, BBS, BTM, MSD, SHP, ENP, 9T9, MPC, AAR, BIO, GBL, MAK, PNT, EQN, MOM, RKS, AVN, PEN, CLT, PPR